Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-21

Clinical Trial Update: Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ketorolac as an adjuvant for pain control after arthroscopic ACL surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: ACL Injury, Postoperative Pain | Phase 3 | Status: COMPLETED | Results posted: 2021-12-21